SNS-314 Mesylate is primarily utilized in the field of oncology research as a potent and selective inhibitor of Aurora kinases, which are crucial enzymes involved in cell division and proliferation. Its application is significant in studying the mechanisms of cancer cell growth and identifying potential therapeutic targets. Researchers employ this compound to investigate its effects on tumor suppression and to evaluate its efficacy in preclinical models of various cancers. Additionally, SNS-314 Mesylate serves as a valuable tool in understanding the role of Aurora kinases in mitosis and their contribution to the development of drug resistance in cancer cells. This makes it a promising candidate for the development of novel anticancer therapies.